• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular biological studies on a role of Aβ production and degrading enzyme in experimental model.

Research Project

Project/Area Number 15591239
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Psychiatric science
Research InstitutionSAPPORO MEDICAL UNIVERSITY

Principal Investigator

TSUZUKI Kayo  SAPPORO MEDICAL UNIVERSITY, SCHOOL OF MEDICINE, INSTRUCTOR, 医学部, 助手 (60207420)

Co-Investigator(Kenkyū-buntansha) FUKATSU Ryo  SAITAMA MEDICAL SCHOOL, PROFESSOR, 医学部, 教授 (10113614)
木村 浩一  北海道立衛生研究所, 微生物細菌科, 科長 (90177915)
Project Period (FY) 2003 – 2005
Project Status Completed (Fiscal Year 2005)
Budget Amount *help
¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 2005: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 2004: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 2003: ¥1,100,000 (Direct Cost: ¥1,100,000)
KeywordsAlzheimer's disease / amyloid β protein / BACE / neprilysin / amyloid precursor protein / BACE gene / Chloroquine rat / myocyte / アミロイドβタンパク / ノックアウト / アミロイドβ蛋白 / PCR / APP遺伝子 / 抗原賦活化処理
Research Abstract

Deposition of amyloid β protein (Aβ) in the brain is an invariant neuropathological feature of Alzheimer's disease (AD). Aβ is generated by two cleavages of amyloid precursor protein (APP). The initial cleavage by BACE is followed by γ-secretase cleavage of the C-terminal APP fragment. Once formed, Aβ is mainly degraded small regulatory peptides by neprilysin (NEP). The generative process of AD is linked to a shift in the balance between Aβ production and degradation. We investigated the possible functional significance of BACE and NEP in cultured myocyte systems under chloroquine (CQN) as an experimental model to study APP processing for Aβ production.
1.Human myocyte (CCL136) was transfected with mutation APPcDNA. The APPmRNA level reached the maximum after 12 hours CQN treatment. Microvacuoles were appeared in perinuclear area 12 hours after CQN treatment, and increased in number until up to 24 hours. Red granular materials around these vacuoles, and inside the vacuoles were stained … More modified Gomori-trichrome.
2.Perinuclear and heterogeneous materials surrounding vacuoles containing stained granular bodies reacted with anti Aβ antibody. Double labeling with anti Aβ and anti BACE antibodies, demonstrated that Aβ and BACE were co-localized in some of the vacuoles.
3.4,12,20,28,60,70 kDa bands were detected using anti Aβ antibody, 12,35,40,70 kDa bands were detected using anti BACE antibody, 70,80 kDa bands were detected using anti NEP antibody by Western blotting. 4 kDa band, apparently Aβ, became remarkable after CQN treatment.
4.BACEmRNA levels were reduced 50% in the siRNA treated myocyte cells relative to control. Double immunostaining of BACEmRNA knockdown myocyte with anti Aβ and anti BACE antibodies, immunoreactivities were co-localized in some of the microvacuoles, but apparently decreased in number
5.NEPmRNA vector was tranfected into myocyte using Lipofectamine. The recombinant myocyte which increased of NEPmRNA level is not provided at present.
CQN myocyte system is a good experimental model to study the balance between the generation and degradation of Aβ appears altered. Less

Report

(4 results)
  • 2005 Annual Research Report   Final Research Report Summary
  • 2004 Annual Research Report
  • 2003 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi